ATE518005T1 - Verfahren zur diagnose und prognose von morbus alzheimer - Google Patents
Verfahren zur diagnose und prognose von morbus alzheimerInfo
- Publication number
- ATE518005T1 ATE518005T1 AT04767370T AT04767370T ATE518005T1 AT E518005 T1 ATE518005 T1 AT E518005T1 AT 04767370 T AT04767370 T AT 04767370T AT 04767370 T AT04767370 T AT 04767370T AT E518005 T1 ATE518005 T1 AT E518005T1
- Authority
- AT
- Austria
- Prior art keywords
- prognosis
- alzheimer
- diagnosis
- disease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Neurosurgery (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0307501A FR2856409B1 (fr) | 2003-06-20 | 2003-06-20 | Methodes de detection de la maladie d'alzheimer |
PCT/FR2004/001509 WO2004113568A2 (fr) | 2003-06-20 | 2004-06-17 | Méthodes de détection de la maladie d'alzheimer |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE518005T1 true ATE518005T1 (de) | 2011-08-15 |
Family
ID=33484616
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04767370T ATE518005T1 (de) | 2003-06-20 | 2004-06-17 | Verfahren zur diagnose und prognose von morbus alzheimer |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP1639139B1 (de) |
JP (1) | JP4691491B2 (de) |
KR (1) | KR101170651B1 (de) |
CN (1) | CN1809645B (de) |
AR (1) | AR044492A1 (de) |
AT (1) | ATE518005T1 (de) |
AU (1) | AU2004249919B2 (de) |
BR (1) | BRPI0411658A (de) |
CA (1) | CA2529633C (de) |
CY (1) | CY1111970T1 (de) |
DK (1) | DK1639139T3 (de) |
ES (1) | ES2370491T3 (de) |
FR (1) | FR2856409B1 (de) |
HK (1) | HK1090392A1 (de) |
HR (1) | HRP20110778T1 (de) |
IL (1) | IL172690A0 (de) |
MX (1) | MXPA05012800A (de) |
NO (1) | NO20060257L (de) |
PL (1) | PL1639139T3 (de) |
PT (1) | PT1639139E (de) |
RU (2) | RU2380423C2 (de) |
SI (1) | SI1639139T1 (de) |
TW (1) | TWI352738B (de) |
WO (1) | WO2004113568A2 (de) |
ZA (1) | ZA200509945B (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103013989A (zh) * | 2011-09-23 | 2013-04-03 | 深圳北京大学香港科技大学医学中心 | 与老年痴呆症发病相关的细胞周期依赖性激酶5的单核苷酸多态性位点 |
GB201212084D0 (en) * | 2012-07-06 | 2012-08-22 | Randox Lab Ltd | Tropomyosin isoforms related to alzheimers disease and mild cognitive impairment |
CN102768189B (zh) * | 2012-07-30 | 2014-11-19 | 黄石 | 一种药物筛选方法 |
CN104313144B (zh) * | 2014-10-16 | 2017-02-01 | 卫生部北京医院 | 一种检测阿尔茨海默病易感性的试剂 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5853995A (en) * | 1997-01-07 | 1998-12-29 | Research Development Foundation | Large scale genotyping of diseases and a diagnostic test for spinocerebellar ataxia type 6 |
EP1210422A2 (de) * | 1999-08-20 | 2002-06-05 | Active Pass Pharmaceuticals, Inc. | Humaner abc2 transporter und dessen verwendungen |
AU2001276995C1 (en) * | 2000-07-20 | 2006-10-26 | Cephalon, Inc. | Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring |
JP2004147502A (ja) * | 2000-07-26 | 2004-05-27 | Banyu Pharmaceut Co Ltd | ヒト及びラットabca2遺伝子 |
US20020169137A1 (en) * | 2001-02-09 | 2002-11-14 | Active Pass Pharmaceuticals, Inc. | Regulation of amyloid precursor protein expression by modification of ABC transporter expression or activity |
WO2002101392A2 (en) * | 2001-06-08 | 2002-12-19 | Xenon Genetics, Inc. | Methods for treating disorders of the nervous and reproductive systems |
-
2003
- 2003-06-20 FR FR0307501A patent/FR2856409B1/fr not_active Expired - Fee Related
-
2004
- 2004-06-09 AR ARP040101994A patent/AR044492A1/es active IP Right Grant
- 2004-06-17 KR KR1020057024490A patent/KR101170651B1/ko not_active IP Right Cessation
- 2004-06-17 DK DK04767370.2T patent/DK1639139T3/da active
- 2004-06-17 RU RU2006101561/13A patent/RU2380423C2/ru not_active IP Right Cessation
- 2004-06-17 PL PL04767370T patent/PL1639139T3/pl unknown
- 2004-06-17 JP JP2006516300A patent/JP4691491B2/ja not_active Expired - Fee Related
- 2004-06-17 CN CN2004800172750A patent/CN1809645B/zh not_active Expired - Fee Related
- 2004-06-17 CA CA2529633A patent/CA2529633C/fr not_active Expired - Fee Related
- 2004-06-17 RU RU2009104533/10A patent/RU2483108C2/ru not_active IP Right Cessation
- 2004-06-17 EP EP04767370A patent/EP1639139B1/de not_active Expired - Lifetime
- 2004-06-17 WO PCT/FR2004/001509 patent/WO2004113568A2/fr active Application Filing
- 2004-06-17 BR BRPI0411658-5A patent/BRPI0411658A/pt not_active IP Right Cessation
- 2004-06-17 AT AT04767370T patent/ATE518005T1/de active
- 2004-06-17 SI SI200431759T patent/SI1639139T1/sl unknown
- 2004-06-17 ES ES04767370T patent/ES2370491T3/es not_active Expired - Lifetime
- 2004-06-17 MX MXPA05012800A patent/MXPA05012800A/es active IP Right Grant
- 2004-06-17 AU AU2004249919A patent/AU2004249919B2/en not_active Ceased
- 2004-06-17 PT PT04767370T patent/PT1639139E/pt unknown
- 2004-06-18 TW TW093117572A patent/TWI352738B/zh not_active IP Right Cessation
-
2005
- 2005-12-07 ZA ZA200509945A patent/ZA200509945B/en unknown
- 2005-12-19 IL IL172690A patent/IL172690A0/en not_active IP Right Cessation
-
2006
- 2006-01-18 NO NO20060257A patent/NO20060257L/no not_active Application Discontinuation
- 2006-10-10 HK HK06111103.5A patent/HK1090392A1/xx not_active IP Right Cessation
-
2011
- 2011-10-26 HR HR20110778T patent/HRP20110778T1/hr unknown
- 2011-10-27 CY CY20111101024T patent/CY1111970T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE435012T1 (de) | Verfahren zur behandlung von parkinson-krankheit | |
DE60219111D1 (de) | Verfahren und System zur Diagnose von Turbinenmotoren | |
DE502004009299D1 (de) | Verfahren zur Herstellung von Niobsuboxid | |
DE60109311D1 (de) | Kit zur simultanen diagnose mehrerer ansteckender krankheiten und verfahren zu seiner herstellung | |
DK2211183T3 (da) | Fremgangsmåde til diagnosticering og overvågning af Alzheimer's sygdom | |
DE60010309D1 (de) | Verfahren zur echtzeitdarstellung von medizinischen bildern | |
ATE463997T1 (de) | Körperreinigungstuch und verfahren zur herstellung | |
DE60302682D1 (de) | Verfahren zur Herstellung von Nanopartikeln | |
ATE304062T1 (de) | Vollnarbiges rindnappaleder und verfahren zur herstellung desselben | |
ATE382631T1 (de) | Verfahren zur herstellung von virusinaktiviertem humanem gammaglobulin g | |
DE60333195D1 (de) | Verfahren zur diagnose des myokardinfarktrisikos | |
DE602004018249D1 (de) | Verfahren zur Dearomatisierung von Molkeprotein | |
ZA200603178B (en) | Quick test for the diagnosis of Alzheimer's disease | |
DE60225953D1 (de) | Verfahren zur Herstellung von Polyamid | |
DE50200467D1 (de) | SPM-Sensor und Verfahren zur Herstellung desselben | |
DE10242955B4 (de) | Kunststoffaß und Verfahren zur Herstellung des Fasses | |
DE602004011865D1 (de) | Vorrichtung und Verfahren zur Bestimmung des Körpertyps | |
ATE518005T1 (de) | Verfahren zur diagnose und prognose von morbus alzheimer | |
DE60328756D1 (de) | Verfahren zur herstellung von chiralen n-aryl piperazinen | |
DE602004027840D1 (de) | Verfahren zur herstellung von thiazolopyrimidinen | |
DE602004005239D1 (de) | Verfahren zur herstellung von tubulininhibitoren | |
DE60302979D1 (de) | Verfahren zur Herstellung von Epsilon-Caprolactone | |
ATE286037T1 (de) | Verfahren zur herstellung von 5-substituierten isobenzofuranen | |
EP1693671A4 (de) | Verfahren zur diagnose von morbus alzheimer | |
DE602004014957D1 (de) | Verfahren zur herstellung von wärmeempfindlichen bebilderbaren elementen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1639139 Country of ref document: EP |